Listed by the USPTO as HAGOPIAN, CASEY SHEA
Tech Center 1600 • Art Units: 1611 1615 1616 1617
This examiner grants 54% of resolved cases
Casey Shea Hagopian has overseen 571 resolved cases in Art Unit 1611, which is part of Tech Center 1600. The examiner's allowance rate is 54.3 percent, and the median days to allowance is 1216. These figures are relevant for top companies like 3M Company, Glogenix LLC, and Globus Medical Inc.
The interview lift of 33.4 percent is a significant statistic, indicating that interviews substantially improve the 54.3 percent baseline allowance rate. Firms such as Knobbe, Martens, Olson & Bear, LLP, Norton Rose Fulbright US LLP, and SUGHRUE MION, PLLC should prioritize oral advocacy. The 33.4 percent lift suggests that the examiner is open to resolving issues through direct discussion during the 1216-day median pendency.
With 571 resolved cases, the data provides a clear picture of the examiner's performance. The 54.3 percent allowance rate and 1216-day median pendency are primary benchmarks for applicants. The 33.4 percent lift is a powerful tool for practitioners looking to increase their chances of a grant in Art Unit 1611.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18046281 | Thermoresponsive or Shear-Thinning Injectable Gel Compositions for Treatment of Arthritis | Final Rejection | GLOBUS MEDICAL, INC. |
| 19119944 | ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | Non-Final OA | Solventum Intellectual Properties Company |
| 18870174 | ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | Non-Final OA | Solventum Intellectual Properties Company |
| 18875297 | ORAL CARE COMPOSITION COMPRISING A PEROXIDE AND AN ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK COPOLYMER | Non-Final OA | BASF SE |
| 17671071 | ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR | Final Rejection | The Regents of the University of California |
| 19045529 | ENDOSCOPE VISUAL FIELD-SECURING VISCOELASTIC COMPOSITION | Non-Final OA | Otsuka Pharmaceutical Factory, Inc. |
| 17753790 | HIGH LOAD FORMULATION CONTAINING A SULFOPOLYMER | Non-Final OA | Eastman Chemical Company |
| 18714810 | A PERSONAL CARE COMPOSITION | Final Rejection | Conopco Inc., d/b/a UNILEVER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.3% of resolved applications examined by Casey Shea Hagopian were allowed (571 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +33.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Casey Shea Hagopian took 1,216 days on average from filing to allowance.
Casey Shea Hagopian examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
